FILE – A grower cuts psilocybin mushrooms to prepare for distribution in Springfield, Ore., Monday, Aug. 14, 2023. Naturally occurring substances like psilocybin, a fungus, can’t be patented by themselves. (AP Photo/Craig Mitchelldyer, File)
Money is pouring into the fledgling psychedelic medicine industry, with dozens of startup companies vying to be among the first to sell mind-expanding drugs for depression, addiction and other mental health conditions.
While psychedelics are still illegal under federal law, companies are jostling to try and patent key ingredients found in magic mushrooms, ayahuasca and other substances that have been used underground for decades or — in some cases — for millennia by indigenous cultures.
Already a Subscriber? Sign in
The Canadian Press. All rights reserved.
JOIN THE CONVERSATION
Anyone can read Conversations, but to contribute, you should be a registered Metroland account holder. If you do not yet have a Metroland account, you can create …